A Phase 3, Randomized, Double-Blind, Placebo-ControlledStudy Assessing the Efficacy and Safety Of Anti-SpikeSARS-CoV-2 Monoclonal Antibodies in Preventing SARSCov-2 Infection in Household Contacts of IndividualsInfected with SARS-CoV-2

Project: Research project

Project Details

Description

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety Of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARSCov- 2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2
StatusActive
Effective start/end date9/1/20 → 9/30/25

Funding

  • REGENERON PHARMACEUTICALS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint